Search

everythinglearnresearchcommunity

for

Search:↓

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Finasteride affects prostate weights and pituitary activity differently with age.

Treatment during development affects hormone balance and sexual behavior in male rats.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Certain genetic variants increase the risk of aggressive prostate cancer.

Corn silk extract helps reduce prostate enlargement symptoms.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

PP2Acα is essential for proper hair and skin development.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

AGA affects many, progresses differently, and early treatment is crucial.

% free PSA and urinary markers help better identify prostate cancer.

The method ensures accurate finasteride measurement in low-dose drugs, but variability must be checked for each case.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Dihydrotestosterone might cause migraines, and finasteride could help reduce them.

MSC-derived EVs show promise for therapy, but production and understanding need improvement.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.